Additional information
| Language | |
|---|---|
| Capability | |
| Region | |
| Industry |
Description
With the UK’s default to leave the EU without a deal, there are a number of steps businesses in the life sciences sector should take to prepare. Many companies in the sector are faced with simultaneously navigating an increasingly complex regulatory environment while trying to mitigate as much as possible the significant impact of Brexit – including the effects of weak drug development pipelines, access to talent, supply chain disruption and potentially reduced research and development (R&D) funding.
Only logged in customers who have purchased this product may leave a review.
You may also like
-
Axbility ConsultingBefore starting an S2P project, it is necessary to be aware that data related topics are crucial to ensure a proper operation of the solution. Our clients often do not enough focus on data issues and do not consider data as one of the pillars to succeed in implementing their S2P project.
12 Recommendation to Implement a Source-To-Pay Solution
$0.00 Axbility Consulting
-
Oliver WymanAutomotive 2030
Building The Automotive Industry of 2030
$0.00 Oliver Wyman
-
DeloitteSUPPLY chains traditionally are linear in nature, with a discrete progression of design, plan, source, make, and deliver. Today, however, many supply chains are transforming from a staid sequence to a dynamic, interconnected system that can more readily incorporate ecosystem partners and evolve to a more optimal state over time.
The rise of the digital supply network
$0.00 Deloitte
Trouble with Conavigo
Trouble with Conavigo?
Contact our support team if you have trouble with the search results, your account, or your message box. We are here to help.
Ads Customers
Ads Consultants
Ads Students
Reviews
There are no reviews yet.